clinical trial of herbal pharacogenomics for prediction of Efficacy and adversity of Bangpungtongsung-san and Bangkihwangki-tang by oriental obesity pattern identification in obesity treatment

clinical trial of herbal pharacogenomics for prediction of Efficacy and adversity of Bangpungtongsung-san and Bangkihwangki-tang by oriental obesity pattern identification in obesity treatment: A Phase 3 Randomized , Double Blinded, placebo-controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000387

Enrollment

132

Registered

2012-03-22

Start date

2009-09-01

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : -administration of Bangpungtongsung-san and Bangkihwangki-tang for 8 weeks -3 times a day, 4 capsules per administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The inclusion criteria for this study are as follows; a. All men and women aged between 18 and 65 years b. BMI>25kg/m2 C. patients who have not undergone weight reduction no more than 3 kilograms within 3 months d. patients who have not attempted to lose weight within a month e. patients not in illness, with generally good health condition f. non smokers(if a patient was a smoker, who have given up for more than 1 year) g. patients who do not exercise h. patients who have been explained about the trial and agreed to the consent

Exclusion criteria

Exclusion criteria: a. patient with past history of heart disease, kidney disease, liver disease or cancer b. patients who are on drugs that can affect body composition and metabolism c. patients with drug sensitivity d. pregnant women

Design outcomes

Primary

Measure	Time frame
ratio of participants with more than 5% of weight reduction compared with baseline	—

Secondary

Measure	Time frame
resting metabolism rate;value of weight change ;waist circumference;body fat ratio;muscle mass;cholesterol level;HDL cholesterol level;triglyceride;Korean version of Obesity-related Quality of Life Scale	—

Countries

Korea, Republic of

Contacts

Public ContactHojun Kim

Dongguk University Ilsan Hospital

Outcome results